Your browser doesn't support javascript.
loading
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.
Tada, Toshifumi; Kumada, Takashi; Hiraoka, Atsushi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Matono, Tomomitsu; Aoki, Tomoko; Kuroda, Hidekatsu; Yata, Yutaka; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Kudo, Masatoshi.
Afiliación
  • Tada T; Department of Gastroenterology, Japanese Red Cross Society Himeji Hospital, Himeji, Hyogo, Japan.
  • Kumada T; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
  • Hiraoka A; Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Yahaba-cho, Iwate, Japan.
  • Hirooka M; Department of Nursing, Gifu Kyoritsu University, Ogaki, Gifu, Japan.
  • Kariyama K; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan.
  • Tani J; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
  • Atsukawa M; Department of Gastroenterology, Okayama City Hospital, Okayama, Okayama, Japan.
  • Takaguchi K; Department of Gastroenterology and Hepatology, Kagawa University, Miki-cho, Kagawa, Japan.
  • Itobayashi E; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
  • Fukunishi S; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan.
  • Tsuji K; Department of Gastroenterology, Asahi General Hospital, Asahi, Chiba, Japan.
  • Ishikawa T; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
  • Tajiri K; Department of Gastroenterology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Ochi H; Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Hokkaido, Japan.
  • Yasuda S; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Niigata, Japan.
  • Toyoda H; Department of Gastroenterology, Toyama University Hospital, Toyama, Toyama, Japan.
  • Ogawa C; Hepato-biliary Center, Japanese Red Cross Matsuyama Hospital, Matsuyama, Ehime, Japan.
  • Nishimura T; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.
  • Hatanaka T; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.
  • Kakizaki S; Department of Gastroenterology, Japanese Red Cross Takamatsu Hospital, Takamatsu, Kagawa, Japan.
  • Shimada N; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
  • Kawata K; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Gunma, Japan.
  • Tada F; Department of Clinical Research, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan.
  • Ohama H; Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Chiba, Japan.
  • Nouso K; Department of Hepatology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Morishita A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan.
  • Tsutsui A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan.
  • Nagano T; Department of Gastroenterology, Okayama City Hospital, Okayama, Okayama, Japan.
  • Itokawa N; Department of Gastroenterology and Hepatology, Kagawa University, Miki-cho, Kagawa, Japan.
  • Okubo T; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan.
  • Arai T; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan.
  • Imai M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
  • Kosaka H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
  • Naganuma A; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
  • Matono T; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Niigata, Japan.
  • Aoki T; Department of Surgery, Kansai Medical University, Hirakata, Osaka, Japan.
  • Kuroda H; Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan.
  • Yata Y; Department of Internal Medicine, Himeji St. Mary's Hospital, Himeji, Hyogo, Japan.
  • Koizumi Y; Department of Gastroenterology and Hepatology, Kindai University, Sayama, Osaka, Japan.
  • Nakamura S; Department of Gastroenterology, Hanwa Memorial Hospital, Osaka, Osaka, Japan.
  • Kaibori M; Department of Gastroenterology, Hanwa Memorial Hospital, Osaka, Osaka, Japan.
  • Iijima H; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
  • Hiasa Y; Department of Gastroenterology, Japanese Red Cross Society Himeji Hospital, Himeji, Hyogo, Japan.
  • Kudo M; Department of Surgery, Kansai Medical University, Hirakata, Osaka, Japan.
Liver Int ; 44(1): 113-124, 2024 01.
Article en En | MEDLINE | ID: mdl-37789669

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Bevacizumab / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Liver Int Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Bevacizumab / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Liver Int Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón